Lista de obras -

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.

artículo científico publicado en 2011

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

artículo científico publicado en 2009

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

artículo científico publicado en 2012

Directly acting antivirals against hepatitis C virus

artículo científico publicado en 2011

HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain

article

Hepatitis C therapy with HCV NS5B polymerase inhibitors

artículo científico publicado en 2013

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

artículo científico publicado en 2011

Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

artículo científico publicado en 2011

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

artículo científico

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses

artículo científico publicado en 2011

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

artículo científico publicado en 2012

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

artículo científico publicado en 2005

Pharmacogenetics of hepatitis C.

artículo científico publicado en 2011

Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain

artículo científico publicado en 2011

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

artículo científico publicado en 2010

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

artículo científico publicado en 2013

Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

artículo científico publicado en 2005

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

artículo científico publicado en 2013

The changing face of hepatitis C in the new era of direct-acting antivirals.

artículo científico publicado en 2012

Treatment failure with new hepatitis C drugs

artículo científico

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.

artículo científico publicado en 2013

Lista de obras de

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

Directly acting antivirals against hepatitis C virus

HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

Pharmacogenetics of hepatitis C.

Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

The changing face of hepatitis C in the new era of direct-acting antivirals.

Treatment failure with new hepatitis C drugs

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.